The neuroATLANTIC network is mainly focused on early detection non-invasive techniques of Alzheimer and stroke. It is funded to promote research and access of companies to its results in order to develop new solutions to improve the lives of patients with neurological diseases.
The project is already showing important results that could be exploited for various applications in the field of biotechnology. These results are public, regularly updated and available on the neuroATLANTIC website. CSG is in charge of establishing connections between companies and institutions willing to collaborate.